Gene therapy for prostate cancer: New perspectives on an old problem

Urologic Clinics of North America

Volumn 26, Issue 2, 1999, Pages 353-363

  Palapattu, G S ^a   Naitoh, J ^a   Belldegrun, A S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; MYC PROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN BCL 2; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; CANCER IMMUNOTHERAPY; CLINICAL TRIAL; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTATE CANCER; PROTO ONCOGENE; RETROVIRUS; REVIEW; SUICIDE GENE; TUMOR SUPPRESSOR GENE; VACCINIA VIRUS;

EID: 0032937229     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70075-6     Document Type: Article

References (75)

1. W.F. Anderson Human gene therapy Nature 392 1998 25
2. K.C. Balaji H. Koul S. Mitra Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: A novel therapy in prostate cancer Urology 50 1997 1007
3. C.J. Berman Davidson B. Lubaroff D. Use of adenovirus delivered herpes thymidine kinase gene for cyto-reductive therapy of prostate cancer using the Dunning rat model J Urol 157 1997 37A
4. R.V. Blackburn S.S. Galoforo P.M. Corry Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells Cancer Res 58 1998 1358
5. S.F. Brewster J.C. Gingell K.W. Brown Tumor suppressor genes in urinary tract oncology Br J Urol 70 1992 585
6. V. Budker G. Zhang I. Danko The efficient expression of intravascularly delivered DNA in rat muscle Gene Ther 5 1998 272
7. G. Casey The BRCA1 and BRCA2 breast cancer genes Curr Opin Oncol 9 1997 88
8. H.H. Chen L.M. Mack R. Kelly Persistence in muscle of an adenoviral vector that lacks all viral genes Proc Natl Acad Sci USA 94 1997 1645
9. Da Costa L.T. J. Jen T.C. He Converting cancer gene into killer genes Proc Natl Acad Sci USA 93 1996 4192
10. J.A. Eastham S.J. Hall I. Sehgal In vivo gene therapy with p53 or p21 adenovirus for prostate cancer Cancer Res 55 1995 5151
11. S. Fan J.A. Wang R.Q. Yuan BRCA1 as a potential human prostate tumor suppressor: Modulation of proliferation, damage responses and expression of cell regulatory proteins Oncogene 16 1998 3069
12. P.L. Felgner Y.J. Tsai L. Sukhu Improved cationic lipid formulations for in vivo gene therapy Ann NY Acad Sci 772 1995 126
13. K.J. Fisher K. Jooss J. Alston Recombinant adeno-associated virus for muscle directed gene therapy Nat Med 3 1997 306
14. Y. Furuya S. Akimoto K. Yasuda Apoptosis of androgen-independent prostate cell line induced by inhibition of fatty acid synthesis Anticancer Res 17 1997 4589
15. F. Garrido F. Ruiz-Cabello MHC expression on human tumors—its relevance for local tumor growth and metastasis Semin Cancer Biol 2 1991 3
16. A. Gotoh S.C. Ko T. Shirakawa Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer J Urol 160 1998 220
17. G.D. Grossfeld A.F. Olumi J.A. Connolly Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity J Urol 159 1998 1437
18. Y. Guo N. Kyprianou Overexpression of transforming growth factor (TGF) betal type II receptor restores TGF-betal sensitivity and signaling in human prostate cancer cells Cell Growth Differ 9 1998 185
19. S.E. Haecker H.H. Stedman R.J. Balice-Gordon In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes Hum Gene Ther 7 1996 1907
20. S.A. Hall S.E. Mutchnik S.H. Chen Adenovirus mediated herpes simplex virus-thymidine kinase gene and gancyclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer Hum Gene Ther 6 1995 1417
21. S.A. Hall S.E. Mutchnik M. Shaker Adenovirus mediated herpes simplex virus thymidine kinase gene transduction and gancyclovir treatment for prostate cancer: Suppression of metastasis in an orthotopic model and synergism with androgen ablation J Urol 155 1996 528A
22. D. He Z.M. Mu X. Le Adenovirus-mediated expression of PML suppresses growth and tumorigencity of prostate cancer cells Cancer Res 57 1997 1868
23. E.A. Hirschowitz A. Ohwada W.R. Pascal In vivo adenovirus mediated gene transfer of E. coli cytosine deaminase gene to human colon carcinoma derived tumors induces chemosensitization to 5-flurocytosine Hum Gene Ther 6 1995 1055
24. Human Gene Therapy Protocols: ORDA/NIH Internet Site. www.nih.gov/od/orda/protocol.htm . Update 5-18-98.
25. T. Ichikawa Y. Ichikawa J.T. Isaacs Genetic factors and suppression of metastatic ability of prostate cancer Cancer Res 51 1991 3788
26. W.B. Isaacs B.S. Carter C.M. Ewing Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles Cancer Res 51 1991 4716
27. D. Jolly Viral vector systems for gene therapy Cancer Gene Ther 1 1994 51
28. W.G. Kearns S.A. Afione S.B. Fulmer Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line Gene Ther 3 1996 748
29. P.J. Kostenuik G. Singh F.W. Orr Transforming growth factor beta upregulates the integrin mediated adhesion of human prostatic cells to type I collagen Clin Exp Metastasis 15 1997 41
30. M.L. Lamm S.M. Sintich C. Lee A proliferative effect of transforming growth factor-betal on a human prostate cancer cell line, TSU-Pr1 Endocrinology 139 1998 787
31. C.T. Lee S. Wu I.F. Ciernik Genetic immunotherapy of established tumors with adenovirus murine granulocyte macrophage colony stimulating factor Hum Gene Ther 8 1997 187
32. D. Lew S.E. Parker T. Latimer Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice Hum Gene Ther 6 1995 553
33. R.M. Linden K.I. Berns Site-specific integration by adeno-associated virus: A basis for a potential gene therapy vector Gene Ther 4 1997 4
34. W.M. Linehan Molecular genetics of tumor suppressor genes in prostate carcinoma J Urol 147 1992 808
35. D. MacGrogan R. Bookstein Tumor suppressor genes in prostate cancer Semin Cancer Biol 8 1997 11
36. R.I. Mahato K. Kawabata T. Nomura Physiochemical and pharmacologic characteristics of plasmid DNA/cationic liposome complexes J Pharm Sci 84 1995 1267
37. S.B. Malkowicz J.O. Johnson Gene therapy for prostate cancer Hematol Oncol Clin North Am 12 1998 649
38. McDonnell T. von Eschenbach A. M. Marin Bcl-2 confers resistance to cell death induction by androgen-ablation and chemotherapy in prostate cancer cells J Urol 155 1996 527A
39. B. Moss Vaccinia virus: A tool for research and vaccine development Science 252 1991 1662
40. G.R. Mundy Mechanisms of bone metastasis Cancer 80 1997 1546
41. G. Murphy B. Tjoa H. Ragde Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201–specific peptides from prostate-specific membrane antigen Prostate 29 1996 371
42. J. Naitoh A. Belldegrun CaPCURE's Fourth Meeting: The Cutting Edge of Current Prostate Cancer Research Prostate Cancer and Prostate Diseases 1 1997 48
43. J. Naitoh A. Belldegrun Gene therapy—the future is here: A guide to the practicing urologist Urology 51 1998 367
44. J. Naitoh C.L. Tso R. Kaboo Intraprostatic interleukin-2 (IL-2) gene therapy: Preliminary results of a phase I clinical trial for the treatment of locally advanced prostate cancer AUA Abstract J Urol 159 1998 254
45. L.L. Nielsen D.S. Maneval P53 tumor suppressor gene therapy for cancer Cancer Gene Ther 5 1998 52
46. A. Norman S. Parker D. Lew Preclinical pharmoacokinetics, manufacturing and safety studies supporting a multicenter cancer gene therapy trial Hum Gene Ther 6 1995 549
47. M. Ogasawara S.A. Rosenberg Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma interferon genes Cancer Res 53 1993 3561
48. S. Pang J. Dannull R. Kaboo Identification of a positive regulatory element responsible for tissue specific expression of prostate specific antigen Cancer Res 57 1997 495
49. S. Pang S. Taneja K. Dardashti Prostate tissue specificity of the prostate specific antigen promoter isolated from a patient with prostate cancer Hum Gene Ther 6 1995 1417
50. A.J. Raffo H. Perlman M.W. Chen Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vitro Cancer Res 55 1995 4438
51. R. Rodriguez H.Y. Lim L.M. Bartkowski Identification of diphtheria toxin via screening as a potent cell cycle and p53-independent cytotoxin for human prostate cancer therapeutics Prostate 34 1998 259
52. R. Rodriguez E.R. Schuur H.Y. Lim Prostate attenuated replication competent adenovirus (ARCA) CN706: A selective cytotoxin for prostate-specific antigen–positive prostate cancer cells Cancer Res 57 1997 2559
53. J.A. Roth R.J. Cristiano Gene therapy for cancer: What have we done and where are we going? J Natl Cancer Inst 89 1997 21
54. M.G. Sanda Biological principles and clinical development of prostate cancer gene therapy Semin Urol Oncol 15 1997 43
55. M.G. Sanda S.R. Ayyagari E.M. Jaffee Demonstration of a rational strategy for human prostate cancer gene therapy J Urol 151 1994 622
56. P.T. Scardino H.L. Adler J.R. Herman Herpes simplex virus–thymidine kinase (HSV-tk) mediated gene therapy is safe and active against locally recurrent prostate cancer after irradiation therapy [abstract] Proc Am Soc Oncol 17 1998 308a
57. T. Segawa H. Takebayashi Y. Kakehi Prostate-specific amplification of expanded polyglutamine expression: A novel approach for cancer gene therapy Cancer Res 58 1998 2282
58. S.F. Slovin W.K. Kelly H.I. Scher Immunological approaches for the treatment of prostate cancer Semin Urol Oncol 16 1998 53
59. T.A. Smith M.G. Mehaffey D.B. Kayda Adenovirus mediated expression of therapeutic levels of human factor 9 in mice Nat Genet 5 1993 397
60. M.S. Steiner C.T. Anthony Y. Lu Antisense c-myc retroviral vector suppresses established human prostate cancer Hum Gene Ther 9 1998 747
61. M.S. Steiner A.C. Anthony Y. Lu Gene therapy for the treatment of advanced prostate cancer by in vivo transduction with prostate targeted retroviral vectors expressing antisense c-myc RNA J Urol 155 1996 340A
62. M.S. Steiner E.R. Barrack Transforming growth factor beta 1 overproduction in prostate cancer: Effects on growth in vivo and in vitro Mol Endocrinol 6 1995 15
63. M.S. Steiner J. Lerner M. Greenberg Clinical phase I gene therapy trial using BRCA1 retrovirus is safe [abstract] J Urol 159 1998 132
64. R.A. Steinman B. Hoffman A. Iro Induction of p21 (WAF-1/CIP1) during differentiation Oncogene 9 1994 3389
65. L.D. Stratford-Perricaudet M. Levrero J.F. Chasse Evaluation of the transfer and expression in mice of an enzyme encoding gene using a human adenovirus vector Hum Gene Ther 1 1990 241
66. S.S. Taneja S. Panf P. Cohan Gene therapy: Principles and potential Cancer Surv 23 1995 247
67. B. Tjoa A. Boynton G. Kenny Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity Prostate 128 1996 65
68. B.A. Tjoa S.J. Simmons V.A. Bowes Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides Prostate 36 1998 39
69. J. Vieweg D. Boczkowski K.M. Roberson Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer Cancer Res 55 1995 2366
70. J. Vieweg F.M. Rosenthal R. Bannerji Immunotherapy of prostate cancer in the Dunning rat model: Use of cytokine gene modified tumor vaccines Cancer Res 54 1994 1760
71. M. Viola F. Fromwitz S. Oravez Expression of ras oncogene p21 in prostate cancer N Engl J Med 314 1986 133
72. B.H. Xue Y. Zhang J.A. Sosman Induction of human cytotoxic T-lymphocytes specific for PSA Prostate 30 1997 73
73. I. Yoshimura W.D. Heston B. Gansbacher Cytokine mediated immuno-gene therapy in rat prostate cancer model J Urol 155 1996 789A
74. R.Q. Zheng D.M. Kemeny Inhibition of gene expression by anti-sense oligodeoxynucleotides Clin Exp Immunol 100 1995 380
75. N. Zhu D. Liggit Y. Liu Systemic gene expression after intravenous DNA delivery into adult mice Science 261 1993 209